Table 1.
WHO recommendations for the use of blood components.
Fig 1.
Flowchart of the selection and sampling.
Table 2.
Laboratory and clinical characteristics of transfused and non-transfused patients.
Table 3.
Demographic and hospitalisation characteristics of study population (n = 323).
Table 4.
Comparison of hospitalisation time and stratified costs for transfusion in patients with or without the WHO criteria (n = 323).
Table 5.
Results of the generalised linear modelling (GLM) with hospital stay and cost as the dependent variable (n = 323).